Monopar Therapeutics Presents Long-Term Efficacy and Safety Data for ALXN1840 in Wilson Disease at EASL International Liver Congress 2025
7/5 08:40
Monopar Therapeutics presents positive long-term efficacy and safety data for ALXN1840 in treating Wilson disease at EASL 2025....